About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2014 (2014), Article ID 945127, 8 pages
http://dx.doi.org/10.1155/2014/945127
Review Article

Roles of Bone-Marrow-Derived Cells and Inflammatory Cytokines in Neointimal Hyperplasia after Vascular Injury

Department of Medicine, Division of Cardiology, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8555, Japan

Received 4 October 2013; Revised 22 November 2013; Accepted 21 December 2013; Published 14 January 2014

Academic Editor: Yoshitaka Iso

Copyright © 2014 Makoto Shoji et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Ross, “The pathogenesis of atherosclerosis: a perspective for the 1990s,” Nature, vol. 362, no. 6423, pp. 801–809, 1993. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Ross, “Atherosclerosis—an inflammatory disease,” The New England Journal of Medicine, vol. 340, no. 2, pp. 115–126, 1999. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Saiura, M. Sata, Y. Hirata, R. Nagai, and M. Makuuchi, “Circulating smooth muscle progenitor cells contribute to atherosclerosis,” Nature Medicine, vol. 7, no. 5, pp. 382–383, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Sata, A. Saiura, A. Kunisato et al., “Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis,” Nature Medicine, vol. 8, no. 4, pp. 403–409, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. J. E. Rectenwald, L. L. Moldawer, T. S. Huber, J. M. Seeger, and C. K. Ozaki, “Direct evidence for cytokine involvement in neointimal hyperplasia,” Circulation, vol. 102, no. 14, pp. 1697–1702, 2000. View at Scopus
  6. R. S. Schwartz and T. D. Henry, “Pathophysiology of coronary artery restenosis,” Reviews in Cardiovascular Medicine, vol. 3, no. 5, pp. S4–S9, 2002. View at Scopus
  7. I. M. Van Der Meer, M. P. M. De Maat, M. L. Bots et al., “Inflammatory mediators and cell adhesion molecules as indicators of severity of atherosclerosis: the rotterdam study,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 22, no. 5, pp. 838–842, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Shoji, M. Sata, D. Fukuda et al., “Temporal and spatial characterization of cellular constituents during neointimal hyperplasia after vascular injury: potential contribution of bone-marrow-derived progenitors to arterial remodeling,” Cardiovascular Pathology, vol. 13, no. 6, pp. 306–312, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Dominici, K. Le Blanc, I. Mueller et al., “Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement,” Cytotherapy, vol. 8, no. 4, pp. 315–317, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. D. G. Phinney and D. J. Prockop, “Concise review: Mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair—current views,” Stem Cells, vol. 25, no. 11, pp. 2896–2902, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. D. T. Scadden, “The stem-cell niche as an entity of action,” Nature, vol. 441, no. 7097, pp. 1075–1079, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. T. M. Dexter, P. Simmons, R. A. Purnell, E. Spooncer, and R. Schofield, “The regulation of hemopoietic cell development by the stromal cell environment and diffusible regulatory molecules,” Progress in clinical and biological research, vol. 148, pp. 13–33, 1984. View at Scopus
  13. A. Wilson and A. Trumpp, “Bone-marrow haematopoietic-stem-cell niches,” Nature Reviews Immunology, vol. 6, no. 2, pp. 93–106, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Kawada, J. Fujita, K. Kinjo et al., “Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction,” Blood, vol. 104, no. 12, pp. 3581–3587, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. D. J. Prockop, “Marrow stromal cells as stem cells for nonhematopoietic tissues,” Science, vol. 276, no. 5309, pp. 71–74, 1997. View at Publisher · View at Google Scholar · View at Scopus
  16. D. J. Prockop, C. A. Gregory, and J. L. Spees, “One strategy for cell and gene therapy: harnessing the power of adult stem cells to repair tissues,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 1, pp. 11917–11923, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. C. K. Hashi, Y. Zhu, G.-Y. Yang et al., “Antithrombogenic property of bone marrow mesenchymal stem cells in nanofibrous vascular grafts,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 29, pp. 11915–11920, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. X. Wu, L. Huang, Q. Zhou et al., “Mesenchymal stem cells participating in ex vivo endothelium repair and its effect on vascular smooth muscle cells growth,” International Journal of Cardiology, vol. 105, no. 3, pp. 274–282, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Shoji, A. Oskowitz, C. D. Malone, D. J. Prockop, and R. Pochampally, “Human mesenchymal stromal cells (MSCs) reduce neointimal hyperplasia in a mouse model of flow-restriction by transient suppression of anti-inflammatory cytokines,” Journal of Atherosclerosis and Thrombosis, vol. 18, no. 6, pp. 464–474, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Kitagawa, T. Hara, H. Tsurumi et al., “Cell cycle-dependent priming action of granulocyte colony-stimulating factor (G-CSF) enhances in vitro apoptosis induction by cytarabine and etoposide in leukemia cell lines,” Journal of Clinical and Experimental Hematopathology, vol. 50, no. 2, pp. 99–105, 2010. View at Scopus
  21. D. Orlic, J. Kajstura, S. Chimenti et al., “Mobilized bone marrow cells repair the infarcted heart, improving function and survival,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 18, pp. 10344–10349, 2001. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Minatoguchi, G. Takemura, X.-H. Chen et al., “Acceleration of the healing process and myocardial regeneration may be important as a mechanism of improvement of cardiac function and remodeling by postinfarction granulocyte colony-stimulating factor treatment,” Circulation, vol. 109, no. 21, pp. 2572–2580, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Maekawa, T. Anzai, T. Yoshikawa et al., “Effect of granulocyte-macrophage colony-stimulating factor inducer on left ventricular remodeling after acute myocardial infarction,” Journal of the American College of Cardiology, vol. 44, no. 7, pp. 1510–1520, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. K. C. Wollert, G. P. Meyer, J. Lotz et al., “Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial,” The Lancet, vol. 364, no. 9429, pp. 141–148, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Suzuki, K. Nagashima, M. Arai et al., “Effect of granulocyte colony-stimulating factor treatment at a low dose but for a long duration in patients with coronary heart disease—a pilot study,” Circulation Journal, vol. 70, no. 4, pp. 430–437, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Hasegawa, H. Takano, H. Shiraishi et al., “Intracoronary injection of granulocyte colony-stimulating factor ameliorates the progression of left ventricular remodeling after myocardial ischemia/reperfusion in rabbits,” Circulation Journal, vol. 70, no. 7, pp. 942–944, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. D. Kong, L. G. Melo, M. Gnecchi et al., “Cytokine-induced mobilization of circulating endothelial progenitor cells enhances repair of injured arteries,” Circulation, vol. 110, no. 14, pp. 2039–2046, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. I. Flamme and W. Risau, “Induction of vasculogenesis and hematopoiesis in vitro,” Development, vol. 116, no. 2, pp. 435–439, 1992. View at Scopus
  29. A. Kawamoto and T. Asahara, “Role of progenitor endothelial cells in cardiovascular disease and upcoming therapies,” Catheterization and Cardiovascular Interventions, vol. 70, no. 4, pp. 477–484, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Shoji, Y. Iso, T. Kusuyama et al., “High-dose granulocyte-colony stimulating factor promotes neointimal hyperplasia in the early phase and inhibits neointimal hyperplasia in the late phase after vascular injury,” Circulation Journal, vol. 72, no. 11, pp. 1885–1893, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Kopf, H. Baumann, G. Freer et al., “Impaired immune and acute-phase responses in interleukin-6-deficient mice,” Nature, vol. 368, no. 6469, pp. 339–342, 1994. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Takaoka, H. Suzuki, S. Shioda et al., “Endovascular injury induces rapid phenotypic changes in perivascular adipose tissue,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 30, no. 8, pp. 1576–1582, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. T. Oguro, Y. Takahashi, T. Ashino et al., “Involvement of tumor necrosis factor α, rather than interleukin-1α/β or nitric oxides in the heme oxygenase-1 gene expression by lipopolysaccharide in the mouse liver,” FEBS Letters, vol. 516, no. 1–3, pp. 63–66, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. H. Yang, M. Li, H. Chai et al., “Expression and regulation of neuropilins and VEGF receptors by TNF-α in human endothelial cells,” Journal of Surgical Research, vol. 122, no. 2, pp. 249–255, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Shibata, H. Sueki, H. Suzuki et al., “Impaired contact hypersensitivity reaction and reduced production of vascular endothelial growth factor in tumor necrosis factor-α gene-deficient mice,” Journal of Dermatology, vol. 32, no. 7, pp. 523–533, 2005. View at Scopus
  36. A. Ozkok, E. Aktas, A. Yilmaz et al., “Decrease in endothelial progenitor cells associated with inflammation, but not with endothelial dysfunction in chronic hemodialysis patients,” Clinical Nephrology, vol. 79, pp. 21–30, 2013. View at Publisher · View at Google Scholar
  37. H. Iwata, I. Manabe, K. Fujiu et al., “Bone marrow-derived cells contribute to vascular inflammation but do not differentiate into smooth muscle cell lineages,” Circulation, vol. 122, no. 20, pp. 2048–2057, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. J. Aoki, P. W. Serruys, H. Van Beusekom et al., “Endothelial progenitor cell capture by stents coated with antibody against CD34: the HEALING-FIM (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth-First in Man) registry,” Journal of the American College of Cardiology, vol. 45, no. 10, pp. 1574–1579, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. S. Silber, P. Damman, M. Klomp et al., “Clinical results after coronary stenting with the Genous bio-engineered R stent: 12-month outcomes of the e-HEALING (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth) worldwide registry,” EuroIntervention, vol. 6, no. 7, pp. 819–825, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. X. Wu, G. Wang, C. Tang et al., “Mesenchymal stem cell seeding promotes reendothelialization of the endovascular stent,” Journal of Biomedical Materials Research A, vol. 98, no. 3, pp. 442–449, 2011. View at Publisher · View at Google Scholar · View at Scopus